Trials / Not Yet Recruiting
Not Yet RecruitingNCT07532213
A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab
Long-Term Use of Guselkumab: Non-interventional Assessment of Real-world Outcomes
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Janssen-Cilag A.G., Switzerland · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate how long guselkumab remains in participants with moderate to severe crohn's disease (CD) or ulcerative colitis (UC) in real-world setting. CD and UC are Inflammatory bowel disease, a group of inflammatory conditions of the colon and small intestine.
Conditions
Timeline
- Start date
- 2026-04-23
- Primary completion
- 2029-04-10
- Completion
- 2029-04-10
- First posted
- 2026-04-15
- Last updated
- 2026-04-15
Source: ClinicalTrials.gov record NCT07532213. Inclusion in this directory is not an endorsement.